StockFetcher Forums · General Discussion · 2008 Lock Of The Year!<< >>Post Follow-up
TheRumpledOne
6,358 posts
msg #62549
Ignore TheRumpledOne
5/13/2008 8:13:35 AM

This came in today:

Congratulations on being one of the chosen few to receive the 2008 Lock Of The Year!

If you would like to speak to one of our traders regarding the premium services at Gryphon Financial
please call 718-370-2883, 800-828-9921 or 212-859-5088.

For more information you can also visit our website at www.gryphonfinancial.net.



--------------------------------------------------------------------------------


The 2008 Lock of the Year Is



Neuralstem Inc (CUR)
Current Price: $2.82 buy up to $5.00


CUR engages in developing and commercializing treatments based on transplanting human neural stem cells. CUR is the only company in the world that I believe has the potential to cure paralyzed humans and make them walk again. The company has already helped paralyzed rats walk again.

CUR uses patent-protected technology that allows them to produce neural stem cells with the ability to control the differentiation of the cells into physiologically relevant human neurons and glia. Once approved by the FDA, these cells could be transplanted into humans as treatments for currently incurable diseases.

By the end of December, CUR is expected to file their first ever Investigational New Drug (IND) application with the FDA. The first IND will be for the treatment of Ischemic Paraplegia, a form of paraplegia that sometimes results from complications in the repair of aortic aneurysms.

CUR expects to begin Phase 1 trials for Ischemic Paraplegia in early 2008!

CUR expects to file a second IND for Traumatic Spinal Cord Injury in the first half of 2008 and begin Phase 1 trials for Traumatic Spinal Cord Injury in the second half of 2008. In late 2008, CUR expects to file a third IND for ALS (also known as Lou Gehrig’s disease).
Check out this article that came out about CUR one week ago in the Maryland Gazette.
Check out this video right now on CUR's web site... showing how they will be doing stem cell transplantation.




13th_floor
724 posts
msg #62570
Ignore 13th_floor
5/13/2008 5:53:37 PM

"Neuralstem Inc (CUR)
Current Price: $2.82 buy up to $5.00 "

Really really nice,so much for newletters.

Beautiful downtrending chart since this newsletter was released.
Current price is now 1.58

Still a few days before you can get it under $5.00 HAHA

Believe these junk newletters and their great stories at your own risk.

DocMartens
3 posts
msg #62774
Ignore DocMartens
5/18/2008 9:06:46 PM

lol

TheRumpledOne
6,358 posts
msg #70093
Ignore TheRumpledOne
12/29/2008 9:41:19 AM

Looks like high since I posted was $2.24.

If you traded CUR during the year, there were some nice runs.

Dems in control...stem cells should do well.





StockFetcher Forums · General Discussion · 2008 Lock Of The Year!<< >>Post Follow-up

*** Disclaimer *** StockFetcher.com does not endorse or suggest any of the securities which are returned in any of the searches or filters. They are provided purely for informational and research purposes. StockFetcher.com does not recommend particular securities. StockFetcher.com, Vestyl Software, L.L.C. and involved content providers shall not be liable for any errors or delays in the content, or for any actions taken based on the content.


Copyright 2016 - Vestyl Software L.L.C.Terms of Service | License | Questions or comments? Contact Us
EOD Data sources: DDFPlus & CSI Data Quotes delayed during active market hours. Delay times are at least 15 mins for NASDAQ, 20 mins for NYSE and Amex. Delayed intraday data provided by DDFPlus